A patient with multiple paraphilias who had been treated for several years with sex drive reducing agents (cyproterone acetate and medroxyprogesterone acetate) with little effect on sexual activity or fantasy was offered treatment with long-acting leuprolide acetate, an LHRH agonist. This produced a marked decrease in all reported sexual thoughts and activities with no significant side-effects.
References
1.
FreundK.Therapeutic sex drive reduction. Acta Psychiatr Scand1980; 62(287 Suppl): 1–38.
2.
BerlinFS, MeinickeCF. Treatment of sex offenders with anti-androgenic medication: conceptualization, review of the treatment modalities, and preliminary findings. Am J Psychiatry1981; 138: 601–607.
3.
BradfordJMW, PawlakA.Sadistic homosexual paedophilia: treatment with cyproterone acetate. A single case study. Can J Psychiatry1987; 32(1): 22–31.
4.
GagneP.Treatment of sex offenders with medroxyprogesterone acetate. Am J Psychiatry1981; 138: 644–646.
5.
CooperAJ. Medroxyprogesterone acetate (MPA) treatment of sexual acting out in men suffering from dementia. J Clin Psychiatry1987; 48: 368–370.
6.
DickeyR.Pharmacologic treatment of sexually anomalous behavior. Drug Protocol1989; 4: 7–10.
7.
Compendium of pharmaceuticals and specialties, twenty-sixth edition. Ottawa ON: Canadian Pharmaceutical Association, 1991.
8.
TolisG, MehtaA, Comaru-SchallyAM, Suppression of androgen production by d-tryptophan-6-luteinizing hormone-releasing hormone in man. J Clin Invest1981; 68: 819–822.
9.
RousseauL, DupontA, LabrieF, Sexuality changes in prostate cancer patients receiving antihormonal therapy combining the antiandrogen flutamide with medical (LHRH agonist) or surgical castration. Arch Sex Behav1988; 17: 87–98.
10.
AllolioB, KeffelD, DeussU, Behandlung sexueller verhaltensstorungen mit LH-RH-superagonisten. Dtsch Med Wschr1985; 110: Jg., Nr. 50: 1952.
11.
RousseauL, CoutureM, DupontA, Effect of combined androgen blockade with an LHRH agonist and flutamide in one severe case of male exhibitionism. Can J Psychiatry1990: 35(4): 338–341.
12.
CasperRF. Clinical uses of gonadotropin-releasing hormone analogues. Can Med Assoc J1991; 144: 153–158.
13.
HuckerS, LangevinR, BainJ.A double blind trial of sex drive reducing medication in pedophiles. Annals of Sex Research1988; 1: 227–242.
14.
LindeR, DoelleGC, AlexanderN, Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men. N Engl J Med1981; 305: 663–667.
15.
FreundK.Psychophysiological assessment of change in erotic preferences. Behav Res Ther1977; 15: 297–301.
